Soiken Holdings Inc. (2385.T)
JPY 128.0
(-0.78%)
JPY 128.0
(-0.78%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.48 Billion JPY | -33.2% |
| 2022 | 3.71 Billion JPY | -12.78% |
| 2021 | 4.26 Billion JPY | 3.59% |
| 2020 | 4.11 Billion JPY | -3.16% |
| 2019 | 4.24 Billion JPY | 6.6% |
| 2018 | 3.98 Billion JPY | 27.6% |
| 2017 | 3.12 Billion JPY | 26.87% |
| 2016 | 2.46 Billion JPY | 31.27% |
| 2015 | 1.87 Billion JPY | 28.66% |
| 2014 | 1.45 Billion JPY | 4.35% |
| 2013 | 1.39 Billion JPY | 10.99% |
| 2012 | 1.25 Billion JPY | 22.72% |
| 2011 | 1.02 Billion JPY | -0.83% |
| 2010 | 1.03 Billion JPY | 2.13% |
| 2009 | 1.01 Billion JPY | -26.89% |
| 2008 | 1.38 Billion JPY | -23.78% |
| 2007 | 1.81 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q4 | 642.07 Million JPY | 39.15% |
| 2023 FY | 2.48 Billion JPY | -33.2% |
| 2023 Q1 | 536.69 Million JPY | -18.06% |
| 2023 Q2 | 842.18 Million JPY | 56.92% |
| 2023 Q3 | 461.41 Million JPY | -45.21% |
| 2022 Q1 | 1.05 Billion JPY | 8.01% |
| 2022 FY | 3.71 Billion JPY | -12.78% |
| 2022 Q4 | 654.99 Million JPY | -36.88% |
| 2022 Q3 | 1.03 Billion JPY | 7.3% |
| 2022 Q2 | 967.08 Million JPY | -8.43% |
| 2021 Q3 | 917.76 Million JPY | -24.01% |
| 2021 Q2 | 1.2 Billion JPY | 4.4% |
| 2021 Q1 | 1.15 Billion JPY | 47.45% |
| 2021 FY | 4.26 Billion JPY | 3.59% |
| 2021 Q4 | 977.78 Million JPY | 6.54% |
| 2020 Q2 | 1.27 Billion JPY | 4.48% |
| 2020 Q1 | 1.21 Billion JPY | 21.9% |
| 2020 Q4 | 784.54 Million JPY | -6.16% |
| 2020 Q3 | 836.06 Million JPY | -34.34% |
| 2020 FY | 4.11 Billion JPY | -3.16% |
| 2019 Q4 | 999.79 Million JPY | 5.36% |
| 2019 FY | 4.24 Billion JPY | 6.6% |
| 2019 Q1 | 1.12 Billion JPY | 25.73% |
| 2019 Q2 | 1.17 Billion JPY | 4.43% |
| 2019 Q3 | 948.94 Million JPY | -19.17% |
| 2018 Q4 | 894.18 Million JPY | -3.57% |
| 2018 Q2 | 996.3 Million JPY | -14.58% |
| 2018 FY | 3.98 Billion JPY | 27.6% |
| 2018 Q1 | 1.16 Billion JPY | 46.6% |
| 2018 Q3 | 927.26 Million JPY | -6.93% |
| 2017 Q3 | 710.01 Million JPY | -11.61% |
| 2017 Q2 | 803.28 Million JPY | -1.25% |
| 2017 FY | 3.12 Billion JPY | 26.87% |
| 2017 Q1 | 813.48 Million JPY | 24.26% |
| 2017 Q4 | 795.57 Million JPY | 12.05% |
| 2016 Q4 | 654.66 Million JPY | 10.78% |
| 2016 Q1 | 628.47 Million JPY | -0.48% |
| 2016 FY | 2.46 Billion JPY | 31.27% |
| 2016 Q2 | 586.96 Million JPY | -6.6% |
| 2016 Q3 | 590.94 Million JPY | 0.68% |
| 2015 FY | 1.87 Billion JPY | 28.66% |
| 2015 Q4 | 631.51 Million JPY | 33.66% |
| 2015 Q3 | 472.46 Million JPY | 7.28% |
| 2015 Q2 | 440.42 Million JPY | 33.31% |
| 2015 Q1 | 330.37 Million JPY | -8.44% |
| 2014 Q3 | 327.42 Million JPY | -22.26% |
| 2014 FY | 1.45 Billion JPY | 4.35% |
| 2014 Q4 | 360.83 Million JPY | 10.2% |
| 2014 Q1 | 347.77 Million JPY | 20.78% |
| 2014 Q2 | 421.16 Million JPY | 21.1% |
| 2013 Q3 | 370.22 Million JPY | -6.44% |
| 2013 Q1 | 342.57 Million JPY | 23.63% |
| 2013 Q2 | 395.71 Million JPY | 15.51% |
| 2013 Q4 | 287.93 Million JPY | -22.23% |
| 2013 FY | 1.39 Billion JPY | 10.99% |
| 2012 Q1 | 399.16 Million JPY | 40.27% |
| 2012 Q3 | 268.15 Million JPY | -14.52% |
| 2012 Q2 | 313.72 Million JPY | -21.41% |
| 2012 FY | 1.25 Billion JPY | 22.72% |
| 2012 Q4 | 277.09 Million JPY | 3.33% |
| 2011 FY | 1.02 Billion JPY | -0.83% |
| 2011 Q4 | 284.57 Million JPY | 25.02% |
| 2011 Q3 | 227.62 Million JPY | -17.52% |
| 2011 Q1 | 237.02 Million JPY | 0.96% |
| 2011 Q2 | 275.98 Million JPY | 16.43% |
| 2010 Q2 | 310.75 Million JPY | 23.12% |
| 2010 Q3 | 235.82 Million JPY | -24.11% |
| 2010 FY | 1.03 Billion JPY | 2.13% |
| 2010 Q4 | 234.78 Million JPY | -0.44% |
| 2010 Q1 | 252.4 Million JPY | 3.29% |
| 2009 Q4 | 244.37 Million JPY | 10.1% |
| 2009 FY | 1.01 Billion JPY | -26.89% |
| 2009 Q1 | 237.83 Million JPY | -46.07% |
| 2009 Q2 | 308.07 Million JPY | 29.53% |
| 2009 Q3 | 221.95 Million JPY | -27.95% |
| 2008 Q4 | 441.01 Million JPY | 91.15% |
| 2008 FY | 1.38 Billion JPY | -23.78% |
| 2008 Q2 | 410.25 Million JPY | 35.6% |
| 2008 Q1 | 302.55 Million JPY | 0.0% |
| 2008 Q3 | 230.71 Million JPY | -43.76% |
| 2007 FY | 1.81 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 1.88 Billion JPY | -31.95% |
| PRISM BioLab Co.,LTD | 80.3 Million JPY | -2991.143% |
| GNI Group Ltd. | 22.43 Billion JPY | 88.933% |
| Linical Co., Ltd. | 3.77 Billion JPY | 34.299% |
| Trans Genic Inc. | 2.24 Billion JPY | -10.364% |
| MEDINET Co., Ltd. | 98.25 Million JPY | -2426.537% |
| Cytori Cell Research Institute, Inc. | 1.29 Billion JPY | -92.043% |
| AnGes, Inc. | -3.06 Billion JPY | 180.983% |
| OncoTherapy Science, Inc. | -177.71 Million JPY | 1496.804% |
| Nxera Pharma Co., Ltd. | 9.66 Billion JPY | 74.313% |
| Immuno-Biological Laboratories Co., Ltd. | 517.29 Million JPY | -379.878% |
| NanoCarrier Co., Ltd. | 110.95 Million JPY | -2137.259% |
| Carna Biosciences, Inc. | 1.45 Billion JPY | -71.128% |
| CanBas Co., Ltd. | -984 Million JPY | 352.274% |
| D. Western Therapeutics Institute, Inc. | 391.69 Million JPY | -533.747% |
| RaQualia Pharma Inc. | 1.65 Billion JPY | -49.888% |
| Chiome Bioscience Inc. | 398.59 Million JPY | -522.781% |
| Kidswell Bio Corporation | 1.03 Billion JPY | -138.831% |
| PeptiDream Inc. | 17.21 Billion JPY | 85.583% |
| Oncolys BioPharma Inc. | 30.6 Million JPY | -8011.005% |
| Ribomic Inc. | -10.5 Million JPY | 23737.145% |
| SanBio Company Limited | -14.5 Million JPY | 17215.092% |
| Healios K.K. | 108 Million JPY | -2198.494% |
| BrightPath Biotherapeutics Co., Ltd. | -341 Thousand JPY | 728068.622% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -59.04 Million JPY | 4304.134% |
| Delta-Fly Pharma, Inc. | -1.51 Million JPY | 164278.108% |
| StemRIM | -44.34 Million JPY | 5697.36% |
| CellSource Co., Ltd. | 3.18 Billion JPY | 22.061% |
| FunPep Company Limited | -680.28 Million JPY | 464.901% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -3484.654% |
| Stella Pharma Corporation | 217.29 Million JPY | -1042.382% |
| TMS Co., Ltd. | -6.95 Million JPY | 35817.597% |
| Noile-Immune Biotech Inc. | 314.56 Million JPY | -689.155% |
| Cuorips Inc. | 9.63 Million JPY | -25674.821% |
| K Pharma,Inc. | 910 Million JPY | -172.788% |
| Takara Bio Inc. | 25.45 Billion JPY | 90.249% |
| ReproCELL Incorporated | 1.1 Billion JPY | -124.706% |
| PhoenixBio Co., Ltd. | 1.19 Billion JPY | -107.72% |
| StemCell Institute Inc. | 1.57 Billion JPY | -57.523% |
| Japan Tissue Engineering Co., Ltd. | 1.66 Billion JPY | -48.932% |
| CellSeed Inc. | 107.15 Million JPY | -2216.619% |